Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Identifying which cash back cards are worth it can enhance your financial strategy. Explore the top options for maximizing rewards.
25,607 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Layoffs are being used to finance AI deployments as global AI expenditure rockets toward trillions. CEOs insist the ...
UniCredit announces a $40 billion bid for Germany’s second-largest bank with a 4% premium, but early signals point to...
A new Stanford study finds tax refunds do little to blunt the impact of higher gasoline prices on American households...
Nasdaq-100 levered ETFs are back in focus as markets swing. While 3x exposure offers amplified moves, daily resets ma...
AI is reshaping the data center landscape, and Marvell is at the center of the action. This piece breaks down why mar...
The U.K. edition of Saturday Night Live is renewed for a second season, underscoring a new model where social-clip vi...
Rent the Runway announces that Jenn Hyman will step down as CEO, with a transition plan that keeps her involved as an...
A major portfolio move by Deepwater Asset Management shaved nearly half of its stake in Global-E Online. Here’s what ...
A recently retired federal worker demonstrates a disciplined budget that keeps $8,000 per month viable. Through daily...
Illinois regulators approve a sweeping regulatory framework for home equity investments, drawing praise from CHEP as ...
Gen X savers still trail target retirement balances, but new guidance shows practical steps—like catch-up contributio...